Klow

Klow is APEX 100's most comprehensive blend formulation—an 80mg quad-compound vial co-lyophilizing TB-500 (10mg), BPC-157 (10mg), GHK-Cu (50mg), and KPV (10mg) into a single research-ready lyophilized powder. Each component has an independent peer-reviewed literature base; the combination covers overlapping but mechanistically non-redundant pathways relevant to tissue remodeling, inflammatory signaling, and extracellular matrix biology.

TB-500 and BPC-157 anchor the tissue-repair dimension of the blend through complementary actin dynamics and nitric oxide system interactions respectively, while GHK-Cu—at its 50mg concentration—provides the formulation’s dominant signal for extracellular matrix remodeling and antioxidant gene expression networks. KPV, a C-terminal alpha-MSH tripeptide (Lys-Pro-Val), contributes the inflammatory modulation axis documented in preclinical gut and skin tissue models.

All four components are synthesized separately under cGMP-equivalent protocols, independently verified to ≥99% purity, then precision-blended and co-lyophilized. A full Certificate of Analysis is included with every order.

For research and laboratory use only. Not for human consumption.